Coda Biotherapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Out of Business

Coda Biotherapeutics General Information

Description

Developer of chemogenetic technology designed to treat neuropathic pain, epilepsy, movement disorders, and other severe nervous system disorders. The company's technology utilizes viral vectors and engineered neurotransmitters to target neurons and reduces pain, enabling healthcare providers to treat nervous system disorders with greater efficiency than traditional therapies.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 240 East Grand Avenue
  • 1st Floor
  • South San Francisco, CA 94080
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 240 East Grand Avenue
  • 1st Floor
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coda Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business Completed Out of Business
6. Later Stage VC 02-Dec-2021 Completed Pre-Clinical Trials
5. Grant 10-Nov-2020 Completed Pre-Clinical Trials
4. Grant 30-Sep-2020 Completed Pre-Clinical Trials
3. Later Stage VC (Series A) 05-Nov-2019 Completed Pre-Clinical Trials
2. Accelerator/Incubator 15-Jun-2017 $10M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 31-Mar-2017 $10M $10M Completed Startup
To view Coda Biotherapeutics’s complete valuation and funding history, request access »

Coda Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Coda Biotherapeutics’s complete cap table history, request access »

Coda Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of chemogenetic technology designed to treat neuropathic pain, epilepsy, movement disorders, and other severe
Drug Discovery
South San Francisco, CA
32 As of 2022

Boston, MA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Coda Biotherapeutics Competitors (41)

One of Coda Biotherapeutics’s 41 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CervoMed Formerly VC-backed Boston, MA
GenSight Biologics Formerly VC-backed Paris, France
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI
Coave Therapeutics Venture Capital-Backed Paris, France
Verge Labs Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 41 competitors. Get the full list »

Coda Biotherapeutics Patents

Coda Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250152742-A1 Compositions and methods for neurological diseases Pending 18-Feb-2022
US-20240108760-A1 Adeno-associated virus capsids and engineered ligand-gated ion channels for treating focal epilepsy and neuropathic pain Pending 25-Jan-2021
WO-2022159871-A1 Adeno-associated virus capsids and engineered ligand-gated ion channels for treating focal epilepsy and neuropathic pain Inactive 25-Jan-2021
WO-2022040535-A2 Compositions and methods for neurological diseases Inactive 21-Aug-2020
WO-2022040535-A3 Compositions and methods for neurological diseases Inactive 21-Aug-2020 A61P25/00
To view Coda Biotherapeutics’s complete patent history, request access »

Coda Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coda Biotherapeutics Acquisitions (1)

Coda Biotherapeutics’s most recent deal was a Merger/Acquisition with Attenua. The deal was made on 05-Feb-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Attenua 05-Feb-2020 Merger/Acquisition Drug Discovery
To view Coda Biotherapeutics’s complete acquisitions history, request access »

Coda Biotherapeutics FAQs

  • When was Coda Biotherapeutics founded?

    Coda Biotherapeutics was founded in 2014.

  • Where is Coda Biotherapeutics headquartered?

    Coda Biotherapeutics is headquartered in South San Francisco, CA.

  • What is the size of Coda Biotherapeutics?

    Coda Biotherapeutics has 32 total employees.

  • What industry is Coda Biotherapeutics in?

    Coda Biotherapeutics’s primary industry is Drug Discovery.

  • Is Coda Biotherapeutics a private or public company?

    Coda Biotherapeutics is a Private company.

  • What is Coda Biotherapeutics’s current revenue?

    The current revenue for Coda Biotherapeutics is .

  • How much funding has Coda Biotherapeutics raised over time?

    Coda Biotherapeutics has raised $72M.

  • Who are Coda Biotherapeutics’s competitors?

    CervoMed, GenSight Biologics, ONL Therapeutics, Coave Therapeutics, and Verge Labs are some of the 41 competitors of Coda Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process